Mika Newton and Tom Neyarapally discuss how advancements in data, AI tools, and computing power are transforming drug discovery, particularly in oncology. They explore patient-centric approaches, in silico screening, and strategies to reduce the time and cost of bringing new treatments to market.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
